- Home
- CRGO vs TNXP Comparison
CRGO vs TNXP Comparison
Compare CRGO & TNXP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | CRGO | TNXP |
|---|---|---|
| Founded | 2012 | 2007 |
| Country | Spain | United States |
| Employees | N/A | N/A |
| Industry | Blank Checks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 195.4M | 201.0M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | CRGO | TNXP |
|---|---|---|
| Price | $2.32 | $16.26 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $70.00 |
| AVG Volume (30 Days) | 72.5K | ★ 509.0K |
| Earning Date | 11-17-2025 | 11-10-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $28,642,000.00 | $10,299,000.00 |
| Revenue This Year | $26.59 | $2.96 |
| Revenue Next Year | $23.43 | $750.19 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 27.55 | N/A |
| 52 Week Low | $1.72 | $6.76 |
| 52 Week High | $4.42 | $69.97 |
Technical Indicators
Market Signals| Indicator | CRGO | TNXP |
|---|---|---|
| Relative Strength Index (RSI) | 25.25 | 37.99 |
| Support Level | $2.27 | $17.71 |
| Resistance Level | $2.72 | $19.35 |
| Average True Range (ATR) | 0.16 | 1.07 |
| MACD | -0.06 | -0.21 |
| Stochastic Oscillator | 8.42 | 5.40 |
Price Performance
Historical ComparisonAbout CRGO Freightos Limited Ordinary shares
Freightos Ltd operates as a vendor-neutral booking and payment platform for international freight. Its platform supports supply chain efficiency and agility by enabling real-time procurement of ocean and air shipping across more than ten thousand importers/exporters. forwarders, and dozens of airlines and ocean carriers. WebCargo by Freightos is a freight platform connecting carriers and forwarders in particular an air cargo eBooking platform. Freightos.com is a digital international freight marketplace for importers and exporters for instant pricing, booking, and shipment management. The company operates in two segments-Platform segment and Solutions segment. Geographically, the company operates in Europe, Hong Kong, United States which is majority revenue generator and others.
About TNXP Tonix Pharmaceuticals Holding Corp.
Tonix Pharmaceuticals Holding Corp is a biopharmaceutical company focused on developing, licensing and commercializing therapeutics to treat and prevent human disease and alleviate suffering. Tonix's development portfolio is focused on central nervous system (CNS) disorders. The company's immunology development portfolio consists of biologics to address organ transplant rejection, autoimmunity and cancer, including TNX-1500, which is a humanized monoclonal antibody targeting CD40-ligand (CD40L or CD154) being developed for the prevention of allograft rejection and for the treatment of autoimmune diseases. Tonix also has product candidates in development in the areas of rare disease and infectious disease.